Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
79
-
Total shares
-
33.7M
-
Shares change
-
-2.07M
-
Total reported value, excl. options
-
$82.3M
-
Value change
-
-$28.5M
-
Put/Call ratio
-
0.87
-
Number of buys
-
38
-
Number of sells
-
-34
-
Price
-
$2.44
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q2 2022
81 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q2 2022.
AVADEL PHARMACEUTICALS - COM (AVDL) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.7M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.74M shares), GENDELL JEFFREY L (4.26M shares), COWEN AND COMPANY, LLC (3.73M shares), BRANDES INVESTMENT PARTNERS, LP (3.63M shares), Vivo Capital, LLC (2.94M shares), Polar Capital Holdings Plc (2.81M shares), WEALTH EFFECTS LLC (2.58M shares), Woodline Partners LP (1.59M shares), RENAISSANCE TECHNOLOGIES LLC (854K shares), and PURA VIDA INVESTMENTS, LLC (789K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.